The content on this site is intended for healthcare professionals only
Dr Carmen Criscitiello speaks at EONS 10, opening the session with a poll of attendees to assess current understandings and awareness of CDK 4/6 therapies.
CDKs were also discussed at an ecancer symposium at ESMO 2016.
Supported by a grant from Pfizer Inc.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in radiology Tanzania
Overview of the management of HER2-low breast cancer patients
